Vancomycin heteroresistance in methicillin-resistant Staphylococcus aureus, Taiwan [12]

Emerging Infectious Diseases

Volumn 10, Issue 9, 2004, Pages 1702-1704

  Wang, Jiun Ling ^a   Tseng, Sung Pin ^a   Hsueh, Po Ren ^a   Hiramatsu, Keiichi ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; LINEZOLID; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CEREBROVASCULAR DISEASE; DEBRIDEMENT; DRUG BLOOD LEVEL; ENTEROCOCCUS FAECALIS; HEMODIALYSIS; HUMAN; INTESTINE ISCHEMIA; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; SEROPREVALENCE; SKIN ABSCESS; TAIWAN; THROMBOCYTOPENIA; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE DISEASE; VEIN CATHETERIZATION;

EID: 4444277118     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1009.040239     Document Type: Letter

References (10)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997;40:135-6.
2. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350:1670-3.
3. Hsueh PR, Teng LJ, Chen WH, Pan HJ, Chen ML, Chang SC, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother. 2004;48:1361-4
4. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis. 2002;8:132-7.
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edition: approved standard M7-A5. Villanova (PA): The Committee; 2000.
6. Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol. 2002;40:1376-80.
7. Wong SS, Ho PL, Woo PC, Yuen KY. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis. 1999;29:760-7.
8. Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, et al. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg Infect Dis. 2003;9:657-64.
9. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7:277-81.
10. Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, et al. Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis. Antimicrob Agents Chemother. 2003;47:2018-21.